Detalles de la búsqueda
1.
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Pharmacogenet Genomics
; 32(9): 301-307, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36256705
2.
Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation.
J Antimicrob Chemother
; 77(5): 1379-1384, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134959
3.
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
Pharmacology
; 107(3-4): 216-226, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073541
4.
The impact of ABCB1, CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation.
Drug Metab Pers Ther
; 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38943286
5.
Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis.
Life (Basel)
; 13(9)2023 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37763335
6.
Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice.
Free Radic Biol Med
; 208: 229-235, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37573895
7.
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Drug Metab Pers Ther
; 2021 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390638
8.
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Drug Metab Pers Ther
; 37(1): 41-46, 2021 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385896
9.
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.
Drug Metab Pers Ther
; 2020 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887180
10.
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Drug Metab Pers Ther
; 35(1)2020 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32134727
11.
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.
High Blood Press Cardiovasc Prev
; 27(2): 151-156, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32215878
12.
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.
Drug Metab Pers Ther
; 35(3)2020 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32975202
13.
Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery.
High Blood Press Cardiovasc Prev
; 26(5): 413-420, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31617197
14.
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty.
Pharmgenomics Pers Med
; 11: 127-137, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100750
15.
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.
Pharmgenomics Pers Med
; 11: 43-49, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29606886
16.
DART mass spectrometry: a fast screening of solid pharmaceuticals for the presence of an active ingredient, as an alternative for IR spectroscopy.
Drug Test Anal
; 2(6): 292-4, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20564604
Resultados
1 -
16
de 16
1
Próxima >
>>